AVCJ's daily bulletin is taking a short break for the festive holiday season.
Publication will resume on January 5, while the first weekly digest of 2023 is released on January 10. We would like to take this opportunity to wish all AVCJ readers a very merry Christmas and a happy...
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.